(a) The board shall adopt guidelines for the prescription of opioid antagonists.
(b) The guidelines must address:
(1) prescribing an opioid antagonist to a patient to whom an opioid medication is also prescribed; and
(2) identifying patients at risk of an opioid-related drug overdose and prescribing an opioid antagonist to that patient or to a person in a position to administer the opioid antagonist to that patient.
Text of subsection as added by Acts 2017, 85th Leg., R.S., Ch. 386 (S.B. 584 ), Sec. 1
(c) In adopting guidelines under this section, the board:
(1) shall consult with the Texas State Board of Pharmacy;
(2) shall consult materials published by the Substance Abuse and Mental Health Services Administration of the United States Department of Health and Human Services; and
(3) may consult other appropriate materials, including medical journals subject to peer review and publications by medical professional associations.
Text of subsection as added by Acts 2017, 85th Leg., R.S., Ch. 534 (S.B. 315 ), Sec. 6
(c) In adopting guidelines under this section, the board:
(1) shall consult materials published by the Substance Abuse and Mental Health Services Administration of the United States Department of Health and Human Services; and
(2) may consult other appropriate materials, including medical journals subject to peer review and publications by medical professional associations.
Added by Acts 2017, 85th Leg., R.S., Ch. 386 (S.B. 584 ), Sec. 1, eff. September 1, 2017.
Added by Acts 2017, 85th Leg., R.S., Ch. 534 (S.B. 315 ), Sec. 6, eff. September 1, 2017.
